orphenadrine has been researched along with Absence of Voice in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe a case of acute dystonia with atypical onset without relation to changes in dosage and with laryngeal involvement with aphonia, but without dyspnoea." | 1.30 | [Atypical acute dystonia]. ( Mors, NP; Nielsen, AS, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nielsen, AS | 1 |
| Mors, NP | 1 |
1 other study available for orphenadrine and Absence of Voice
| Article | Year |
|---|---|
[Atypical acute dystonia].
Topics: Acute Disease; Adult; Antipsychotic Agents; Aphonia; Dyskinesia, Drug-Induced; Dystonia; Humans; Mal | 1998 |